This review outlines the role of structural and functional biomarkers in screening and assessing cardiovascular prognosis in children with chronic kidney disease.
Biomarkers may aid screening and prognosis in hypertensive children with CKD; leaves open pediatric-specific validation versus adult approaches.
The article provides an overview of current understanding of the risk factors for chronic kidney disease (CKD) and cardiovascular diseases in the pediatric population. The groups of the main structural and functional markers in children with arterial hypertension and CKD in children are considered. The results of studies confirming their value in terms of screening, diagnosis, and assessment of cardiovascular prognosis are presented. Differences in approaches to the use of biomarkers in adults and children are discussed.
No takes yet. Share an insight, caveat, or question.
Karimdzhanov et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: